300 results on '"Roviello, G."'
Search Results
2. Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience
- Author
-
Boccaccino, A., Borelli, B., Intini, R., Antista, M., Bensi, M., Rossini, D., Passardi, A., Tamberi, S., Giampieri, R., Antonuzzo, L., Noto, L., Roviello, G., Zichi, C., Salati, M., Puccini, A., Noto, C., Parisi, A., Rihawi, K., Persano, M., Crespi, V., Libertini, M., Giordano, M., Moretto, R., Lonardi, S., and Cremolini, C.
- Published
- 2022
- Full Text
- View/download PDF
3. State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer
- Author
-
Basile D, Simionato F, Cappetta A, Garattini SK, Roviello G, and Aprile G
- Subjects
gastric cancer ,precision oncology ,her2-inhibitors ,claudine 18.2 inhibitors ,fgfr inhibitors ,Medicine (General) ,R5-920 - Abstract
Debora Basile,1 Francesca Simionato,1 Alessandro Cappetta,1 Silvio Ken Garattini,2 Giandomenico Roviello,3 Giuseppe Aprile1 1Department of Oncology, San Bortolo General Hospital, AULSS8 Berica, Vicenza, Italy; 2Department of Oncology, University Hospital, Udine, Italy; 3Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Firenze, Firenze, ItalyCorrespondence: Giuseppe AprileDepartment of Oncology, AULSS8 Berica, Vicenza, ItalyEmail giuseppe.aprile@aulss8.veneto.itAbstract: Gastric cancer (GC) is a complex and heterogeneous disease with poor prognosis and limited available treatment options. During recent years, several molecular stratifications have been proposed to optimize the overall treatment strategy for GC patients. Breakthroughs in cancer biology and in molecular profiling through DNA and RNA sequencing are now opening novel landscapes, leading to the personalization of molecular matched therapy. In particular, therapies against HER2, Claudine 18.2, Fibroblast Growth Factor Receptors (FGFR), and other molecular alterations could significantly improve survival outcomes in the advance phase of the disease. Furthermore, immunotherapy with checkpoint inhibitors also represents a promising option in a selected population. Hoping that precision oncology will enter soon in clinical practice, our review describes the state of the art of many novel pathways and the current evidence supporting the use of monoclonal antibodies implicated in GC treatment.Keywords: gastric cancer, precision oncology, HER2-inhibitors, Claudine 18.2 inhibitors, FGFR inhibitors
- Published
- 2021
4. EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
- Author
-
Ianza, Anna, Di Chicco, A., Biagi, C., Giudici, F., Dicorato, A., Guglielmi, A., Variola, F., Tomasi, S., Roviello, G., Generali, D., and Zanconati, F.
- Published
- 2021
- Full Text
- View/download PDF
5. FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer
- Author
-
Catalano M, Conca R, Petrioli R, Ramello M, and Roviello G
- Subjects
irinotecan ,oxaliplatin ,second line ,pancreatic cancer ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Martina Catalano,1 Raffaele Conca,2 Roberto Petrioli,3 Monica Ramello,4 Giandomenico Roviello5 1School of Human Health Sciences, University of Florence, Florence 50134, Italy; 2Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero, Vulture (PZ) 85028, Italy; 3Department of Medicine, Surgery and Neurosciences, Medical Oncology Unit, University of Siena, Siena 53100, Italy; 4Oncology Unit, Department of Medical, Surgical, & Health Sciences, University of Trieste, Trieste, Italy; 5Department of Health Sciences, University of Florence, Florence 50139, ItalyCorrespondence: Giandomenico RovielloDepartment of Health Sciences, University of Florence, Viale Pieraccini, 6, Florence 50139, ItalyTel +055-7938313Email giandomenicoroviello@hotmail.itBackground: Several progresses have been achieved for first-line chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) with Gem-NabP and FOLFIRINOX extensively used as standard first line regimens. However, the best second-line chemotherapy choice after progression is still not completely defined. The aim of this study is to compare effectiveness and safety of two possible second-line therapeutic options, FOLFOX and FOLFIRI, after progression to Gem-NabP.Methods: From January 2015 to December 2018, patients with metastatic PDAC, progressed to the first-line treatment with Gem-NabP, and treated with a fluoropyrimidine-based second-line chemotherapy were considered eligible for our retrospective analysis. Overall survival (OS) and progression free survival (PFS) were set as primary endpoints whereas, disease control rate (DCR) and the rate and severity of treatment-related AEs were secondary endpoints.Results: Overall, 31 patients were treated with Gem-NabP in first-line regimen, 11 received second-line with FOLFOX and 20 with FOLFIRI after progression. Baseline demographic and clinic features were similar in the two groups excluding median age of 55.5 years (range: 50– 73) and 68 years (range: 59– 72) in FOLFIRI and FOLFOX groups, respectively (p=0.002). Median PFS was three months (95%CI: 3– 4), with no significative difference between the two groups. Median OS was eight months (95%CI: 5– 10) and was significantly higher in the FOLFIRI group compared with the FOLFOX group, nine months (95%CI: 7– 17) vs five months (95%CI: 2– 10; p< 0.01). The most commonly reported adverse events were grade 1 or 2 with anemia most frequent in the FOLFOX group (36.4% vs 10.0%) and diarrhea in the FOLFIRI group (40.0% vs 9.1%). Grade 3– 4 adverse events as neutropenia, diarrhea and nausea/vomiting, occurred in 10 patients (32.2%) without differences between the two groups.Conclusion: Our results seem to support the use of fluoropyrimidine-based second-line therapy for patients with metastatic pancreatic cancer, confirming the effectiveness and safety, to a greater extent with FOLFIRI regimen, after progression to the Gem-NabP.Keywords: irinotecan, oxaliplatin, second line, pancreatic cancer
- Published
- 2020
6. Neoadjuvant versus adjuvant chemotherapy in muscle-invasive bladder cancer: The RealBLADDER study. Results on behalf of the GOIRC
- Author
-
Gambale, E., primary, GIORGIONE, R., additional, VASCOTTO, I.A., additional, DE GENNARO AQUINO, I., additional, SCOLARI, F., additional, MELA, M.M., additional, CATALANO, M., additional, ROVIELLO, G., additional, DONI, L., additional, GALLI, L., additional, BALDAZZI, V., additional, ATZORI, F., additional, MASINI, C., additional, SCAGLIARINI, S., additional, PILLOZZI, S., additional, BASSO, U., additional, and ANTONUZZO, L., additional
- Published
- 2023
- Full Text
- View/download PDF
7. Thermal cycling stability of fly ash based geopolymer mortars
- Author
-
Colangelo, F., Cioffi, R., Roviello, G., Capasso, I., Caputo, D., Aprea, P., Liguori, B., and Ferone, C.
- Published
- 2017
- Full Text
- View/download PDF
8. Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma
- Author
-
Bonetta A, Roviello G, Generali D, Zanotti L, Cappelletti MR, Pacifico C, and Di Pierro F
- Subjects
enteric-coated ,antibiotic-resistance ,PAC-A ,Vaccinium macrocarpon. ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Alberto Bonetta,1 Giandomenico Roviello,2,3 Daniele Generali,3,4 Laura Zanotti,3 Maria Rosa Cappelletti,3 Chiara Pacifico,5 Francesco Di Pierro6 1Oncological Radiotherapy Operative Unit, ASST, Cremona, 2Department of Molecular and Translational Medicine, University of Brescia, Brescia, 3Molecular Therapy and Pharmacogenomics Unit, ASST, Cremona, 4Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, 5Department of Medical, Surgical and Neurological Sciences, University Hospital of Siena, Siena, 6Velleja Research Scientific Department, Milan, Italy Introduction: Worldwide, bacterial resistance to antibiotic therapy is a major concern for the medical community. Antibiotic resistance mainly affects Gram-negative bacteria that are an important cause of lower urinary tract infections (LUTIs). Pelvic irradiation for prostate cancer is a risk factor for LUTIs. Cranberry extract is reported to reduce the incidence of LUTIs. The prophylactic role of an enteric-coated, highly standardized cranberry extract (VO370®) in reducing LUTI episodes, urinary discomfort, and nonsteroidal anti-inflammatory drug (NSAID) and antibiotic use during radiotherapy for prostate carcinoma was evaluated. Methods: A total of 924 patients with prostate carcinoma treated by radiotherapy to the prostatic and pelvic areas were randomized to receive (n=489) or not (n=435) the enteric-coated, highly standardized cranberry extract for 6–7 weeks concurrently with irradiation. Outcomes were analyzed by using Mann–Whitney U test and Pearson’s X2 test. Primary endpoint was the number of patients with LUTI; secondary endpoints were incidence of recurrence, days of treatment with antibiotics and number of subjects treated with NSAIDs, and incidence of dysuria. Results: The treatment was very well tolerated, and there were no serious side effects. All enrolled patients completed the study. Urinary infections were detected in 53 of the 489 patients (10.8%) treated with enteric-coated, highly standardized cranberry extract, while 107 of the 435 patients (24.6%) in the control group developed LUTIs (p=0.0001). A clear and significant reduction in urinary discomfort of ~50% was seen in treated subjects. The treatment also resulted in ~50% reduction in the use of anti-inflammatory drugs and antibiotics. Conclusion: The enteric-coated, highly standardized cranberry extract could be used as a prophylactic to reduce the incidence of LUTIs and decrease antibiotic therapy in patients receiving pelvic irradiation for prostate cancer. Keywords: antibiotic-resistance, PAC-A, Vaccinium macrocarpon, UTI, E. coli, botanicals
- Published
- 2017
9. Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance status
- Author
-
Roviello, G., Pacifico, C., Polom, K., Roviello, F., and Generali, D.
- Published
- 2017
- Full Text
- View/download PDF
10. Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021
- Author
-
Zhang, K, Tartarone, A, Perez-Rios, M, Novello, S, Mariniello, A, Roviello, G, Zhang, J, Zhang, K, Tartarone, A, Perez-Rios, M, Novello, S, Mariniello, A, Roviello, G, and Zhang, J
- Published
- 2022
11. C32 - Efficacy of extended aromatase inhibitors for hormone-receptor–positive breast cancer: a literature based meta-analysis of randomized trials
- Author
-
Roviello, G., Pagani, O., Meani, F., Strina, C., Zanoni, D., Milani, M., Sohbani, N., Ianza, A., Bortul, M., Zanconati, F., Rossellini, P., and Generali, D.
- Published
- 2017
- Full Text
- View/download PDF
12. P228 - Neoadjuvant versus adjuvant chemotherapy in muscle-invasive bladder cancer: The RealBLADDER study. Results on behalf of the GOIRC
- Author
-
Gambale, E., GIORGIONE, R., VASCOTTO, I.A., DE GENNARO AQUINO, I., SCOLARI, F., MELA, M.M., CATALANO, M., ROVIELLO, G., DONI, L., GALLI, L., BALDAZZI, V., ATZORI, F., MASINI, C., SCAGLIARINI, S., PILLOZZI, S., BASSO, U., and ANTONUZZO, L.
- Published
- 2023
- Full Text
- View/download PDF
13. Synthesis of novel MMT/acyl-protected nucleo alanine monomers for the preparation of DNA/alanyl-PNA chimeras
- Author
-
Roviello, G. N., Gröschel, S., Pedone, C., and Diederichsen, U.
- Published
- 2010
- Full Text
- View/download PDF
14. Synthesis, characterization and hybridization studies of an alternate nucleo-ε/γ-peptide: complexes formation with natural nucleic acids
- Author
-
Roviello, G. N., Musumeci, D., Pedone, C., and Bucci, E. M.
- Published
- 2010
- Full Text
- View/download PDF
15. Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer:a systematic review and meta-analysis of preclinical studies
- Author
-
Sahlolbei, Maryam, Dehghani, Mohsen, Kheiri Yeghane Azar, Behghat, Vafaei, Somayeh, Roviello, G, D'Angelo, Alberto, Madjd, Zahra, and Kiani, Jafar
- Subjects
meta-analysis ,antigen ,SDG 3 - Good Health and Well-being ,pancreatic cancer ,Immunology ,Immunology and Allergy ,Animal model ,CAR T-cell - Abstract
One of the cutting edge techniques for treating cancer is the use of the patient's immune system to prevail cancerous disease. The versatility of the chimeric antigen receptor (CAR) T-cell approach in conjugation with promising treatments in haematological cancer has led to countless cases of research literature for the treatment of solid cancer. A systematic search of online databases as well as gray literature and reference lists of retrieved studies were carried out up to March 2019 to identify experimental animal studies that investigated the antigens targeted by CAR T-cell for pancreatic cancer treatment. Studies were evaluated for methodological quality using the SYstematic Review Center for Laboratory Animal Experimentation bias risk tool (SYRCLE's ROB tool). Pooled cytotoxicity ratio/percentage and 95% confidence intervals were calculated using the inverse-variance method while random-effects meta-analysis was used, taking into account conceptual heterogeneity. Heterogeneity was assessed with the Cochran Q statistic and quantified with the I2 statistic using Stata 13.0. Of the 485 identified studies, 56 were reviewed in-depth with 16 preclinical animal studies eligible for inclusion in the systematic review and 11 studies included in our meta-analysis. CAR immunotherapy significantly increased the cytotoxicity assay (percentage: 65%; 95% CI: 46%, 82%). There were no evidence for significant heterogeneity across studies [P = 0.38 (Q statistics), I2 = 7.14%] and for publication bias. The quality assessment of included studies revealed that the evidence was moderate to low quality and none of studies was judged as having a low risk of bias across all domains. CAR T-cell therapy is effective for pancreatic cancer treatment in preclinical animal studies. Further high-quality studies are needed to confirm our finding and a standard approach of this type of studies is necessary according to our assessment.
- Published
- 2020
- Full Text
- View/download PDF
16. 1897P Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations
- Author
-
Massari, F., Pulido, E. Grande, Bamias, A., Iacovelli, R., Cerrillo, J. Molina, Procopio, G., Fiala, O., Myint, Z.W., De Giorgi, U.F.F., Buchler, T., Santini, D., Büttner, T., Roviello, G., Pichler, M., Bourlon de los Rios, M.T., Rizzo, A., Monteiro, F.S.M., Buti, S., Porta, C.G., and Santoni, M.
- Published
- 2023
- Full Text
- View/download PDF
17. Gut microbiome modulation and faecal microbiota transplantation following allogenic hematopoietic stem cell transplantation
- Author
-
Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Kaźmierczak-Siedlecka K; Skonieczna-żydecka K; Biliński J; Roviello G; Iannone LF; Atzeni A; Sobocki BK; Połom K, Bioquímica i Biotecnologia, Universitat Rovira i Virgili, and Kaźmierczak-Siedlecka K; Skonieczna-żydecka K; Biliński J; Roviello G; Iannone LF; Atzeni A; Sobocki BK; Połom K
- Abstract
Nowadays, allogenic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy that is mainly recommended for hematologic malignancies. However, complications (such as graft-versus-host disease, mucositis, disease relapse, and infections) associated with the HSCT procedure contribute to the development of gut microbiota imbalance, gut-barrier disruption, and increased intestinal permeability. In the present narrative review, the crosstalk between gut microbiota products and intestinal homeostasis is discussed. Notably, gut-microbiota-related aspects have an impact on patients’ clinical outcomes and overall survival. In accordance with the most recent published data, gut microbiota is crucial for the treatment effectiveness of many diseases, not only gastrointestinal cancers but also hematologic malignancies. Therefore, it is necessary to indicate a therapeutic method allowing to modulate gut microbiota in HSCT recipients. Currently, fecal microbiota transplantation (FMT) is the most innovative method used to alter/restore gut microbiota composition, as well as modulate its activity. Despite the fact that some previous data have shown promising results, the knowledge regarding FMT in HSCT is still strongly limited, except for the treatment of Clostridium difficile infection. Additionally, administration of prebiotics, probiotics, synbiotics, and postbiotics can also modify gut microbiota; however, this strategy should be considered carefully due to the high risk of fungemia/septicemia (especially in case of fungal probiotics)..
- Published
- 2021
18. 739P Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immuno-oncology: A real-world study on behalf of Meet-URO group (MeetUro-7b)
- Author
-
Stellato, M., primary, Santini, D., additional, Verzoni, E., additional, De Giorgi, U., additional, Casadei, C., additional, Buti, S., additional, Maruzzo, M., additional, Murianni, V., additional, Sbrana, A., additional, Di Lorenzo, G., additional, Anesi, C., additional, Sorarù, M., additional, Naglieri, E., additional, De Vivo, R., additional, Vignani, F., additional, Grillone, F., additional, Mucciarini, C., additional, Roviello, G., additional, Pignata, S., additional, and Procopio, G., additional
- Published
- 2020
- Full Text
- View/download PDF
19. Synthesis, characterization and hybridization studies of an alternate nucleo- ε /γ -peptide: complexes formation with natural nucleic acids
- Author
-
Roviello, G. N., Musumeci, D., Pedone, C., and Bucci, E. M.
- Published
- 2010
- Full Text
- View/download PDF
20. Radiotherapy after prostatectomy in high‑risk prostate cancer
- Author
-
Roviello, G., Villari, D., Nesi, G., and Detti, B.
- Subjects
radiotherapy, prostatectomy - Published
- 2020
21. The impact of translated reminder letters and phone calls on mammography screening booking rates: Two randomised controlled trials
- Author
-
Roviello, G, Beauchamp, A, Mohebbi, M, Cooper, A, Pridmore, V, Livingston, P, Scanlon, M, Davis, M, O'Hara, J, Osborne, R, Roviello, G, Beauchamp, A, Mohebbi, M, Cooper, A, Pridmore, V, Livingston, P, Scanlon, M, Davis, M, O'Hara, J, and Osborne, R
- Abstract
INTRODUCTION: Participation in mammographic screening for breast cancer in Australia is approximately 54% among the general population, but screening among women from some culturally and linguistically diverse (CALD) backgrounds is lower. BreastScreen Victoria apply strategies to increase screening including reminder letters and phone calls; however, these are usually provided in English. Using intervention strategies generated from the Ophelia (OPtimise HEalth LIteracy and Access) community co-design process, translated mammography reminder letters and in-language phone calls were tested within two randomised control trials (RCTs). METHODS AND ANALYSIS: Women aged 50-75 years who were due for their 2-yearly screening mammography (for RCT#1) or were under-screened, i.e. ≥27 months since last screen (for RCT#2) were randomised into intervention or control groups. RCT#1 compared sending women routine reminder letters (English only) with translated (Arabic or Italian) letters. RCT#2 compared reminder telephone calls to women in their preferred language (Arabic or Italian) to no telephone call. The primary outcome for each trial was screening booking rates within 14-days. Primary outcomes were tested using Pearson's chi-square test. Rates within language group (incidence ratio: IR) were compared using the Cochran-Mantel-Haenszel test. RESULTS: For RCT#1 (letters) 1,032 women were randomised into the intervention arm or to usual care. Uptake of screening bookings was similar between both groups, with no differences observed by language group. For RCT#2 (phone calls), 195 women were randomised to the intervention group or to usual care. Overall, 64.2% of women in the intervention arm and 6% in the control arm booked a screening appointment within 14 days (p<0.0001). The IR (95%CI) of booking was 10.1 (3.9, 26.3) times higher among Italian women, and 11.6 (2.9, 46.5) times higher among Arabic women in the intervention compared to usual care groups. DISCUSSION AND CONCLUSIO
- Published
- 2020
22. The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]
- Author
-
Roviello, G, Clarke, SJ, Burge, M, Feeney, K, Gibbs, P, Jones, K, Marx, G, Molloy, MP, Price, T, Reece, WHH, Segelov, E, Tebbutt, NC, Roviello, G, Clarke, SJ, Burge, M, Feeney, K, Gibbs, P, Jones, K, Marx, G, Molloy, MP, Price, T, Reece, WHH, Segelov, E, and Tebbutt, NC
- Abstract
BACKGROUND: In spite of demonstrating prognostic and possibly predictive benefit in retrospective cohorts and meta-analyses of cancer populations, including colorectal cancer (CRC), prospective evaluation of the relationship between neutrophil to lymphocyte ratio (NLR) and treatment outcomes in previously untreated mCRC patients receiving bevacizumab-based therapy has not yet been performed. METHODS: An open-label, single arm, multi-centre study. Patients received first-line bevacizumab plus XELOX or mFOLFOX6 (Phase-A) and continued bevacizumab plus FOLFIRI beyond first progression (Phase-B). Analyses included the association of NLR with phase A progression free survival (PFS) and overall survival (OS). A sub-study investigated the safety in patients with the primary in situ tumor. An exploratory sub-study examined relationships of circulating proteomic markers with PFS. RESULTS: Phase-A enrolled 128 patients; median age was 64 years (range: 26-84), 70 (55%) were female, 71 (56%) were PS-0 and 51 (40%) had primary in situ tumor. Fifty-three (41%) patients entered Phase-B. The median baseline (b) NLR was 3.2 (range: 1.5-20.4) with 32 (25%) patients having bNLR > 5. The PFS hazard ratio (HR) by bNLR > 5 versus ≤ 5 was 1.4 (95% CI: 0.9-2.2; p = 0.101). The median PFS was 9.2 months (95% CI: 7.9-10.8) for Phase-A and 6.7 months (95% CI: 3.0-8.2) for Phase-B. The HR for OS based on bNLR > 5 versus ≤ 5 was 1.6 (95% CI: 1.0-2.7; p = 0.052). The median OS was 25 months (95% CI: 19.2-29.7) for the full analysis set and 14.9 months for Phase-B. Baseline levels of nine proteomic markers showed a relationship with PFS. Treatment related toxicities were consistent with what has previously been published. There were 4 (3%) instances of GI perforation, of which, 3 (6%) occurred in the primary in situ tumor group. CONCLUSIONS: Results from this study are aligned with the previously reported trend towards worse PFS and OS in patients with higher bNLR. TRIAL REGISTRATION: ClinicalTri
- Published
- 2020
23. Solid phase synthesis and RNA-binding activity of an arginine-containing nucleopeptide† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5ra25809j Click here for additional data file
- Author
-
Roviello, G. N., Vicidomini, C., Di Gaetano, S., Capasso, D., Musumeci, D., and Roviello, V.
- Subjects
Chemistry - Abstract
Here we report the solid phase synthesis and characterization (LC-ESIMS, CD) of a cationic nucleobase-containing α-peptide, composed of both l-arginine residues and l-lysine-based nucleoamino acids sequentially present in the structure., Here we report the solid phase synthesis and characterization (LC-ESIMS, CD) of a cationic nucleobase-containing α-peptide, composed of both l-arginine residues and l-lysine-based nucleoamino acids sequentially present in the structure. The binding properties of this novel basic nucleopeptide towards nucleic acids were investigated by CD spectroscopy which revealed the ability of the thymine-containing oligomer to bind both adenine-containing DNA (dA12) and RNA (poly rA) molecules inducing high conformational variations in the nucleic acid structures. Moreover, the artificial oligonucleotide inhibited the enzymatic activity of HIV reverse transcriptase, opening the door to the exploitation of novel antiviral strategies inspired to this molecular tool.
- Published
- 2016
24. Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of response
- Author
-
Roviello, G, Murphy, C, Muscat, A, Ashley, D, Mukaro, V, West, L, Liao, Y, Chisanga, D, Shi, W, Collins, I, Baron-Hay, S, Patil, S, Lindeman, G, Khasraw, M, Roviello, G, Murphy, C, Muscat, A, Ashley, D, Mukaro, V, West, L, Liao, Y, Chisanga, D, Shi, W, Collins, I, Baron-Hay, S, Patil, S, Lindeman, G, and Khasraw, M
- Abstract
BACKGROUND: This study evaluated the feasibility of achieving high response rates in stage II or III breast cancer by tailoring neoadjuvant therapy using clinical and histopathological features and the Oncotype DX Breast Recurrence Score. Genomic determinants of response and resistance were also explored. PATIENTS AND OUTCOME MEASURES: Fifty-one patients were enrolled. The primary cohort comprised 40 patients: 15 human epidermal growth factor receptor type 2 (HER2)-amplified; 15 triple-negative (TNBC); and ten hormone receptor (HR)-positive, HER2-non-amplified tumours; with recurrence scores ≥25. Patients were treated with epirubicin and cyclophosphamide, followed by nab-paclitaxel, with the addition of trastuzumab if HER2-amplified. The primary endpoint was pathological complete response (pCR) in the breast. Pre- and post-treatment tumour samples underwent variant burden, gene and gene pathway, mutational signature profile and clonal evolution analyses. RESULTS: The pCR rates were: overall 55% (n = 22), HER2-amplified 80% (n = 12), triple-negative 46% (n = 7) and HR-positive, HER2-non-amplified 30% (n = 3). Grade 3 or 4 adverse events included febrile neutropenia (8%), neutropenia (18%), sensory neuropathy (5%), deranged transaminases (5%), fatigue (2%), diarrhoea (2%), and pneumothorax (2%). Molecular analyses demonstrated strong similarities between residual disease and matched primary tumour. ATM signalling pathway alterations and the presence of a COSMIC Signature 3 implied the majority of tumours contained some form of homologous repair deficiency. ATM pathway alterations were identified in the subset of TNBC patients who did not achieve pCR; Signature 3 was present in both pCR and non-pCR subgroups. Clonal evolution analyses demonstrated both persistence and emergence of chemoresistant clones. CONCLUSIONS: This treatment regime resulted in a high rate of pCR, demonstrating that tailored neoadjuvant therapy using a genomic recurrence score is feasible and warr
- Published
- 2019
25. Is the Gleason score the driver for the treatment decision-making of patients with castration-resistant prostate cancer in the new era of the anti-androgenic therapies?
- Author
-
Roviello, G. and Generali, D.
- Published
- 2016
- Full Text
- View/download PDF
26. Treatment of an atypical metastatic meningioma: a case report
- Author
-
Francini G, Mazzei Ma, Miracco C, Roviello G, Mastrogiulio Mg, Conca R, Marsili S, and Cerase A
- Subjects
Pathology ,medicine.medical_specialty ,business.industry ,Metastatic Meningioma ,lcsh:R ,lcsh:Medicine ,bevacizumab ,chemotherapeutic agents ,doxorubicin ,hydroxyurea ,nervous system diseases ,medicine ,otorhinolaryngologic diseases ,metastatic meningioma ,business ,neoplasms - Abstract
Meningiomas are common intracranial tumors which usually pursue a benign course. Extracranial metastases from meningiomas are very rare and the lung is the most common site. We report a 27 year old girl with an intracranial atypical meningioma with pulmonary metastasis which had been misdiagnosed as lung sequestration upon chest CT examination. She underwent subtotal surgical resection of the meningioma in 2006 and surgical removal of the lung metastasis in 2009. Then, the patient developed pleural, lung, periesophageal and diaphragmatic nodal metastases, despite only subtle increase of the intracranial residual meningioma. Therefore, she was treated by Doxil (pegylated liposomal doxorubicin) and bevacizumab with a progression of disease after three cycles and then with hydroxyurea for two months with a dimensional increase of metastatic lesions. After adding sorafenib to hydroxyurea the patient showed a further progression disease and finally died for respiratory insufficiency. Metastatic meningiomas have been rarely reported. Hydroxyurea is one of the most used drug in recurrent and metastatic meningiomas, despite modest results are obtained. Further chemotherapy strategies or biological agent must be investigated in clinical trials.
- Published
- 2013
- Full Text
- View/download PDF
27. Efficacy of extended aromatase inhibitors for hormone-receptor–positive breast cancer: a literature based meta-analysis of randomized trials
- Author
-
Roviello, G., primary, Pagani, O., additional, Meani, F., additional, Strina, C., additional, Zanoni, D., additional, Milani, M., additional, Sohbani, N., additional, Ianza, A., additional, Bortul, M., additional, Zanconati, F., additional, Rossellini, P., additional, and Generali, D., additional
- Published
- 2017
- Full Text
- View/download PDF
28. Abstract P4-22-17: Safety of the combination of everolimus plus exemestane in the Italian cohort of patients enrolled in the expanded access “BALLET” study
- Author
-
Generali, D, primary, Bordonaro, R, additional, Febbraro, A, additional, Madoffa, A, additional, Romito, S, additional, Michelotti, A, additional, Savastano, C, additional, Mariani, G, additional, Tondini, C, additional, Piovano, P, additional, Iona, MT, additional, Bighin, C, additional, Roviello, G, additional, Ascione, G, additional, Goffredo, F, additional, Sartori, D, additional, Frassoldati, A, additional, and Simoncini, E, additional
- Published
- 2017
- Full Text
- View/download PDF
29. Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer
- Author
-
Milani, M, Venturini, S, Bonardi, S, Allevi, G, Strina, C, Cappelletti, MR, Corona, SP, Aguggini, S, Bottini, A, Berruti, A, Jubb, A, Campo, L, Harris, AL, Gatter, K, Fox, SB, Generali, D, Roviello, G, Milani, M, Venturini, S, Bonardi, S, Allevi, G, Strina, C, Cappelletti, MR, Corona, SP, Aguggini, S, Bottini, A, Berruti, A, Jubb, A, Campo, L, Harris, AL, Gatter, K, Fox, SB, Generali, D, and Roviello, G
- Abstract
PURPOSE: To identify hypoxia-related biomarkers indicative of response and resistance to epirubicin treatment in patients with locally advanced breast cancer. PATIENTS AND METHODS: One hundred seventy-six women with T2-4 N0-1 breast tumours were randomly assigned to receive epirubicin 120 mg/m2/1-21 (EPI ARM), epirubicin 120 mg/m2/1-21 + erythropoietin 10.000 IU sc three times weekly (EPI-EPO ARM) and epirubicin 40 mg/m2/w-q21 (EPI-W ARM). Sixteen tumour proteins involved in cell survival, hypoxia, angiogenesis and growth factor, were assessed by immunohistochemistry in pre-treatment samples. A multivariate generalized linear regression approach was applied using a penalized least-square minimization to perform variable selection and regularization. RESULTS: VEGF and GLUT-1 expression were significantly positively associated with complete response (CR) to treatment in all leave-one-out iterations. Bcl-2 expression was inversely correlated with pCR, whilst EPO expression was positively correlated with pathological complete response (pCR). Haemaglobin and HIF-1a nuclear expression were inversely correlated with pCR. HB and HIF-1a expression were associated with a higher risk of relapse and overall survival. CONCLUSION: Hypoxic biomarkers determines the epirubicin resistance in breast cancer. Assessment of such biomarkers, may be useful for predicting chemosensitivity and also anthracycline-based treatment outcome.
- Published
- 2017
30. DNA-based strategies for blocking HMGB1 cytokine activity: design, synthesis and preliminary in vitro/in vivo assays of DNA and DNA-like duplexes
- Author
-
Musumeci D, Bucci E, Sapio R, Valente M, Roviello G, Moccia M, Pedone C., BIANCHI , MARCO EMILIO, Musumeci, D, Bucci, E, Sapio, R, Valente, M, Roviello, G, Moccia, M, Bianchi, MARCO EMILIO, and Pedone, C.
- Published
- 2011
31. Ligands derived from sugars: synthesis and characterization of hydrophilic Pt(II) complexes
- Author
-
Cucciolito M. E., Del Litto R., Roviello G., Ruffo F., FANIZZI, Francesco Paolo, MIGONI, DANILO, Cucciolito, M. E., Del Litto, R., Fanizzi, Francesco Paolo, Migoni, Danilo, Roviello, G., and Ruffo, F.
- Published
- 2009
32. Self assembled monolayers based on organometallic thiols: interaction at the interface and molecular organization
- Author
-
VITALIANO R, FRATODDI I, VENDITTI I, ROVIELLO G, BATTOCCHIO, CHIARA, RUSSO M. V., POLZONETTI, Giovanni, Vitaliano, R, Fratoddi, I, Venditti, I, Roviello, G, Battocchio, Chiara, Polzonetti, Giovanni, and Russo, M. V.
- Published
- 2009
33. A COMPUTER MODELING STUDY OF BINDING PROPERTIES OF CHIRAL NUCLEOPEPTIDE FOR BIOMEDICAL APPLICATIONS.
- Author
-
Pirtskhalava, M., Egoyan, A., Mirtskhulava, M., and Roviello, G.
- Published
- 2017
34. Erratum to: Synthesis of novel MMT/acyl-protected nucleo alanine monomers for the preparation of DNA/alanyl-PNA chimeras
- Author
-
Roviello, G. N., primary, Gröschel, S., additional, Pedone, C., additional, and Diederichsen, U., additional
- Published
- 2010
- Full Text
- View/download PDF
35. Synthesis of novel MMT/acyl-protected nucleo alanine monomers for the preparation of DNA/alanyl-PNA chimeras
- Author
-
Roviello, G. N., primary, Gröschel, S., additional, Pedone, C., additional, and Diederichsen, U., additional
- Published
- 2009
- Full Text
- View/download PDF
36. Synthesis, characterization and hybridization studies of an alternate nucleo-ε/γ-peptide: complexes formation with natural nucleic acids
- Author
-
Roviello, G. N., primary, Musumeci, D., additional, Pedone, C., additional, and Bucci, E. M., additional
- Published
- 2008
- Full Text
- View/download PDF
37. Sustainable Materials Based on Geopolymer–Polyvinyl Acetate Composites for Art and Design Applications
- Author
-
Laura Ricciotti, Alessio Occhicone, Stefania Manzi, Andrea Saccani, Claudio Ferone, Oreste Tarallo, Giuseppina Roviello, Ricciotti L., Occhicone A., Manzi S., Saccani A., Ferone C., Tarallo O., Roviello G., Ricciotti, L., Occhicone, A., Manzi, S., Saccani, A., Ferone, C., Tarallo, O., Roviello, G., Ricciotti, Laura, Occhicone, Alessio, Manzi, Stefania, Saccani, Andrea, Ferone, Claudio, Tarallo, Oreste, and Roviello, Giuseppina
- Subjects
Polymers and Plastics ,PVAc ,art and design ,geopolymer ,composites ,green materials ,cultural heritage ,green material ,composite ,General Chemistry - Abstract
The recent introduction of the Next Generation EU packages on the circular economy and the Italian Ecological Transition Plan has further boosted the research of effective routes to design materials with low energy and low environmental impact, in all areas of research, including art and design and cultural heritage. In this work, we describe for the first time the preparation and characterization of a new sustainable adhesive material to be used in the art and design sector, consisting of a geopolymer-based composite with polyvinyl acetate (PVAc), both considered more environmentally acceptable than the analogous inorganic or polymeric materials currently used in this sector. The key idea has been the development of organic–inorganic composites by reacting low molecular weight polymers with the geopolymer precursor to obtain a material with reduced brittleness and enhanced adhesion with common substrates. Structural, morphological, and mechanical studies pointed out the consistent microstructure of the composite materials if compared to the neat geopolymer, showing lower density (up to 15%), improved flexural strength (up to 30%), similar water absorption and a relevant toughening effect (up to 40%). Moreover, the easy pourability in complex shapes and the excellent adhesion of these materials to common substrates suggest their use as materials for restoration, rehabilitation of monuments, and decorative and architectural intervention. The organic–inorganic nature of these new materials also makes them easily recognizable from the support on which they are used, favoring, in line with the dictates of good restoration practices, their possible complete removal. For all these reasons, these new materials could represent promising candidates to overcome the limits related to the creative industry for what concerns the selection of environmentally friendly materials to meet design requirements with low environmental impacts.
- Published
- 2022
- Full Text
- View/download PDF
38. Hybrid Fly Ash-based Geopolymeric Foams: Microstructural, Thermal and Mechanical Properties
- Author
-
Antonio Jacopo Molino, Laura Ricciotti, Giuseppina Roviello, Oreste Tarallo, Domenico Asprone, Constantino Menna, Claudio Ferone, Raffaele Cioffi, Pietro Russo, Veronica Ferrandiz-Mas, Roviello, G., Ricciotti, L., Molino, A. J., Menna, C., Ferone, C., Asprone, D., Cioffi, R., Ferrandiz-Mas, V., Russo, P., Tarallo, O., Roviello, G, Ricciotti, L, Molino, A J, Menna, C, Ferone, C, Asprone, D, Cioffi, R, Ferrandiz-Mas, V, Russo, P, and Tarallo, O
- Subjects
microtomography ,Materials science ,02 engineering and technology ,mechanical properties ,010402 general chemistry ,01 natural sciences ,lcsh:Technology ,Article ,chemistry.chemical_compound ,Thermal conductivity ,polysiloxanes ,Thermal insulation ,Blowing agent ,General Materials Science ,lightweight material ,Composite material ,lcsh:Microscopy ,Lightweigth material ,geopolymer ,lcsh:QC120-168.85 ,hybrid foams ,Fly ash ,Geopolymer ,Hybrid foams ,Lightweight material ,Mechanical properties ,Microtomography ,Polysiloxanes ,lcsh:QH201-278.5 ,business.industry ,lcsh:T ,Polysiloxane ,SDG 8 - Decent Work and Economic Growth ,021001 nanoscience & nanotechnology ,Hybrid foam ,Silicate ,0104 chemical sciences ,Characterization (materials science) ,Compressive strength ,fly ash ,chemistry ,lcsh:TA1-2040 ,lcsh:Descriptive and experimental mechanics ,lcsh:Electrical engineering. Electronics. Nuclear engineering ,SDG 12 - Responsible Consumption and Production ,0210 nano-technology ,business ,lcsh:Engineering (General). Civil engineering (General) ,Mechanical propertie ,lcsh:TK1-9971 - Abstract
This research investigates the preparation and characterization of new organic&ndash, inorganic geopolymeric foams obtained by simultaneously reacting coal fly ash and an alkali silicate solution with polysiloxane oligomers. Foaming was realized in situ using Si0 as a blowing agent. Samples with density ranging from 0.3 to 0.7 g/cm3 that show good mechanical properties (with compressive strength up to &asymp, 5 MPa for a density of 0.7 g/cm3) along with thermal performances (&lambda, = 0.145 ±, 0.001 W/m·, K for the foamed sample with density 0.330 g/cm3) comparable to commercial lightweight materials used in the field of thermal insulation were prepared. Since these foams were obtained by valorizing waste byproducts, they could be considered as low environmental impact materials and, hence, with promising perspectives towards the circular economy.
- Published
- 2020
- Full Text
- View/download PDF
39. GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up
- Author
-
Michele Caraglia, Pierpaolo Correale, Rocco Giannicola, Nicoletta Staropoli, Cirino Botta, Pierpaolo Pastina, Antonello Nesci, Nadia Caporlingua, Edoardo Francini, Laura Ridolfi, Enrico Mini, Giandomenico Roviello, Domenico Ciliberto, Rita Maria Agostino, Alessandra Strangio, Domenico Azzarello, Valerio Nardone, Antonella Falzea, Salvatore Cappabianca, Marco Bocchetti, Graziella D'Arrigo, Giovanni Tripepi, Pierfrancesco Tassone, Raffaele Addeo, Antonio Giordano, Luigi Pirtoli, Guido Francini, Pierosandro Tagliaferri, Caraglia M., Correale P., Giannicola R., Staropoli N., Botta C., Pastina P., Nesci A., Caporlingua N., Francini E., Ridolfi L., Mini E., Roviello G., Ciliberto D., Agostino R.M., Strangio A., Azzarello D., Nardone V., Falzea A., Cappabianca S., Bocchetti M., D'Arrigo G., Tripepi G., Tassone P., Addeo R., Giordano A., Pirtoli L., Francini G., Tagliaferri P., Caraglia, M., Correale, P., Giannicola, R., Staropoli, N., Botta, C., Pastina, P., Nesci, A., Caporlingua, N., Francini, E., Ridolfi, L., Mini, E., Roviello, G., Ciliberto, D., Agostino, R. M., Strangio, A., Azzarello, D., Nardone, V., Falzea, A., Cappabianca, S., Bocchetti, M., D'Arrigo, G., Tripepi, G., Tassone, P., Addeo, R., Giordano, A., Pirtoli, L., Francini, G., and Tagliaferri, P.
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Cancer Research ,Colorectal cancer ,medicine.medical_treatment ,colorectal cancer ,chemotherapy ,lcsh:RC254-282 ,03 medical and health sciences ,0302 clinical medicine ,FOLFOX ,Internal medicine ,Medicine ,Adverse effect ,Original Research ,Chemotherapy ,business.industry ,Hazard ratio ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,GOLFIG ,immunotherapy ,metastatic ,phase III clinical trial ,real-world medicine ,Gemcitabine ,Oxaliplatin ,Regimen ,030104 developmental biology ,030220 oncology & carcinogenesis ,business ,medicine.drug - Abstract
Background: GOLFIG is a chemo-immunotherapy regimen established in preclinical models that combines gemcitabine + FOLFOX (fluoropyrimidine backbone coupled to oxaliplatin) poly-chemotherapy with low-dose s. c. recombinant interleukin-2 (rIL-2) and granulocyte-macrophage colony stimulating factor (GM-CSF). Promising antitumor effects in metastatic colorectal cancer (mCRC) patients were obtained in previous phase II and III trials. Here we report the results of 15 years of follow-up. Methods: This is a multi-institutional retrospective analysis including 179 mCRC patients receiving GOLFIG regimen between June 2002 and June 2018. Sixty-two of them received the treatment as frontline (enrolled in the GOLFIG-2 phase III trial) and 117 as second/third line (49 enrolled in the GOLFIG-1 phase II trial and 68 as compassionate use). One hundred twelve patients showed a primary left side and 67 a primary right side; K/N-ras mutational status was available in 74 cases, and an activating mutation was detected in 33. Kaplan–Meier and Cox regression analyses were carried out to relate PFS and OS with different parameters. Results: Overall, we recorded a mean PFS and OS of 15.28 (95% CI: 10.36–20.20) and 24.6 (95% CI: 19.07–30.14) months, respectively, with 14 patients surviving free of progression for 10 years. This regimen, in our updated survey of the GOLFIG-2 trial, confirmed superiority over FOLFOX in terms of PFS (hazard ratio (HR) = 0.58, p = 0.006) with a trend to a longer OS (HR = 0.69, P = 0.06) in the first line. Our analysis also confirmed significant antitumor activity in pre-treated patients, reporting a mean PFS and OS of 12.55 (95% CI: 7.19–17.9) and 20.28 (95% CI: 14.4–26.13) months, respectively. Immune-related adverse events (irAEs) were recorded in 24% of the cases and were related to a longer survival (HR = 0.36; P = 0.0001). Finally, patients' outcome was not correlated to sex, sidedness, and MT-K/N-ras. Conclusions: The GOLFIG regimen is a reliable underestimated therapeutic option in pre-treated mCRC patients and offers a strong rationale to design further trials.
- Published
- 2019
40. Tensile behaviour of geopolymer-based materials under medium and high strain rates
- Author
-
Domenico Asprone, Laura Ricciotti, Costantino Menna, Claudio Ferone, Anna Bozza, Andrea Prota, Ezio Cadoni, Giuseppina Roviello, Daniele Forni, Cadoni E., Menna, Costantino, Asprone, Domenico, Forni, D., Roviello, G., Ricciotti, L., Ferone, C., Bozza, Anna, Prota, Andrea, Cadoni, E., Menna C, Asprone D, Forni D, Roviello G, Ricciotti L, Ferone C, Bozza A, Prota A, Cadoni E, Menna, C, Asprone, D, Forni, D, Roviello, G, Ricciotti, L, Ferone, C, Bozza, A, Prota, A, and Cadoni, E
- Subjects
High strain ,Geopolymer ,Materials science ,Dynamic loading ,Physics ,QC1-999 ,Ultimate tensile strength ,Research studies ,Mechanical engineering ,Split-Hopkinson pressure bar ,Applied science ,Composite material ,Dynamic load testing - Abstract
Geopolymers are a promising class of inorganic materials typically obtained from an alluminosilicate source and an alkaline solution, and characterized by an amorphous 3-D framework structure. These materials are particularly attractive for the construction industry due to mechanical and environmental advantages they exhibit compared to conventional systems. Indeed, geopolymer-based concretes represent a challenge for the large scale uses of such a binder material and many research studies currently focus on this topic. However, the behaviour of geopolymers under high dynamic loads is rarely investigated, even though it is of a fundamental concern for the integrity/vulnerability assessment under extreme dynamic events. The present study aims to investigate the effect of high dynamic loading conditions on the tensile behaviour of different geopolymer formulations. The dynamic tests were performed under different strain rates by using a Hydro-pneumatic machine and a modified Hopkinson bar at the DynaMat laboratory of the University of Applied Sciences of Southern Switzerland. The results are processed in terms of stress-strain relationships and strength dynamic increase factor at different strain-rate levels. The dynamic increase factor was also compared with CEB recommendations. The experimental outcomes can be used to assess the constitutive laws of geopolymers under dynamic load conditions and implemented into analytical models. © 2015 Owned by the authors, published by EDP Sciences.
- Published
- 2015
41. Less COVID-19 deaths in southern and insular Italy explained by forest bathing, Mediterranean environment, and antiviral plant volatile organic compounds
- Author
-
Valentina Roviello, Giovanni N. Roviello, Roviello, V., and Roviello, G. N.
- Subjects
Mediterranean climate ,Bathing ,Mediterranean diet ,Coronavirus disease 2019 (COVID-19) ,Spike ,Forest bathing ,Biology ,Population density ,chemistry.chemical_compound ,Linalool ,Abundance (ecology) ,Mediterranean vegetation ,Environmental Chemistry ,Volatile organic compounds ,Pandemics ,Original Paper ,Immunomodulatory compound ,Pandemic ,Ecology ,SARS-CoV-2 ,COVID-19 ,Immunomodulatory compounds ,Angiotensin-converting enzyme 2 ,Plant therapeutics ,chemistry ,Plant volatile ,Plant therapeutic ,Receptor binding domain - Abstract
The coronavirus disease 2019 (COVID-19) is causing major sanitary and socioeconomic issues, yet some locations are less impacted than others. While densely populated areas are likely to favor viral transmission, we hypothesize that other environmental factors could explain lower cases in some areas. We studied COVID-19 impact and population statistics in highly forested Mediterranean Italian regions versus some northern regions where the amount of trees per capita is much lower. We also evaluated the affinity of Mediterranean plant-emitted volatile organic compounds (VOCs) isoprene, α-pinene, linalool and limonene for COVID-19 protein targets by molecular docking modeling. Results show that while mean death number increased about 4 times from 2020 to 2021, the percentage of deaths per population (0.06–0.10%) was lower in the greener Mediterranean regions such as Sardinia, Calabria and Basilica versus northern regions with low forest coverage, such as Lombardy (0.33%) and Emilia Romagna (0.29%). Data also show that the pandemic severity cannot be explained solely by population density. Modeling reveals that plant organic compounds could bind and interfere with the complex formed by the receptor binding domain of the coronavirus spike protein with the human cell receptor. Overall, our findings are likely explained by sea proximity and mild climate, Mediterranean diet and the abundance of non-deciduous Mediterranean plants which emit immunomodulatory and antiviral compounds. Potential implications include ‘forest bathing’ as a therapeutic practice, designing nasal sprays containing plant volatile organic compounds, and preserving and increasing forest coverage. Supplementary Information The online version contains supplementary material available at 10.1007/s10311-021-01309-5.
- Published
- 2021
42. Lower COVID-19 mortality in Italian forested areas suggests immunoprotection by Mediterranean plants
- Author
-
Valentina Roviello, Giovanni Roviello, Roviello, V., and Roviello, G. N.
- Subjects
Mediterranean climate ,Population ,Air pollution ,02 engineering and technology ,Forest bathing ,010501 environmental sciences ,01 natural sciences ,Laurus nobili ,Shrubland ,Laurus nobilis ,food ,Mediterranean vegetation ,Per capita ,Environmental Chemistry ,education ,0105 earth and related environmental sciences ,pro ,education.field_of_study ,Original Paper ,geography.geographical_feature_category ,Ecology ,SARS-CoV-2 ,Mortality rate ,COVID-19 ,Evergreen ,021001 nanoscience & nanotechnology ,Plant therapeutics ,food.food ,inhibitor ,Deciduous ,Geography ,Mpro inhibitors ,0210 nano-technology ,Particulate matter ,Plant toxicity ,Plant therapeutic - Abstract
The COVID-19 pandemic has induced dramatic effects on the population of the industrialized north of Italy, whereas it has not heavily affected inhabitants of the southern regions. This might be explained in part by human exposure to high levels of fine particulate matter (PM) in the air of northern Italy, thus exacerbating the mortality. Since trees mitigate air pollution by intercepting PM onto plant surfaces and bolster the human immune system by emitting bioactive volatile organic compounds (VOCs), we hypothesize a protective role of evergreen forested areas in southern Italy. We compared the mortality rate due to COVID-19, the death number, the positivity rate and the forest coverage per capita in various Italian regions. Hectares of forest per capita and prevalence of deciduous versus evergreen forestal species were also estimated. In silico docking studies of potentially protective compounds found in Laurus nobilis L., a typical Mediterranean plant, were performed to search for potential antivirals. We found that the pandemic’s severity was generally lower in southern regions, especially those with more than 0.3 hectares of forest per capita. The lowest mortality rates were found in southern Italy, mainly in regions like Molise (0.007%) and Basilicata (0.005%) where the forest per capita ratio is higher than 0.5 Ha/person. Our findings suggest that evergreen Mediterranean forests and shrubland plants could have protected the southern population by emission of immuno-modulating VOCs and provision of dietary sources of bioactive compounds. Moreover, in silico studies revealed a potential anti-COVID-19 activity in laurusides, which are unexplored glycosides from bay laurel. Overall, our results highlight the importance of nature conservation and applications to the search for natural antivirals. Electronic supplementary material The online version of this article (10.1007/s10311-020-01063-0) contains supplementary material, which is available to authorized users.
- Published
- 2020
43. The Improvement of Durability of Reinforced Concretes for Sustainable Structures: A Review on Different Approaches
- Author
-
Luigi Coppola, Silvia Beretta, Maria Chiara Bignozzi, Fabio Bolzoni, Andrea Brenna, Marina Cabrini, Sebastiano Candamano, Domenico Caputo, Maddalena Carsana, Raffaele Cioffi, Denny Coffetti, Francesco Colangelo, Fortunato Crea, Sabino De Gisi, Maria Vittoria Diamanti, Claudio Ferone, Patrizia Frontera, Matteo Maria Gastaldi, Claudia Labianca, Federica Lollini, Sergio Lorenzi, Stefania Manzi, Milena Marroccoli, Michele Notarnicola, Marco Ormellese, Tommaso Pastore, MariaPia Pedeferri, Andrea Petrella, Elena Redaelli, Giuseppina Roviello, Antonio Telesca, Francesco Todaro, Coppola, Luigi, Beretta, Silvia, Bignozzi, Maria Chiara, Bolzoni, Fabio, Brenna, Andrea, Cabrini, Marina, Candamano, Sebastiano, Caputo, Domenico, Carsana, Maddalena, Cioffi, Raffaele, Coffetti, Denny, Colangelo, Francesco, Crea, Fortunato, De Gisi, Sabino, Diamanti, Maria Vittoria, Ferone, Claudio, Frontera, Patrizia, Gastaldi, Matteo Maria, Labianca, Claudia, Lollini, Federica, Lorenzi, Sergio, Manzi, Stefania, Marroccoli, Milena, Notarnicola, Michele, Ormellese, Marco, Pastore, Tommaso, Pedeferri, MariaPia, Petrella, Andrea, Redaelli, Elena, Roviello, Giuseppina, Telesca, Antonio, Todaro, Francesco, Coppola, L., Beretta, S., Bignozzi, M. C., Bolzoni, F., Brenna, A., Cabrini, M., Candamano, S., Caputo, D., Carsana, M., Cioffi, R., Coffetti, D., Colangelo, F., Crea, F., De Gisi, S., Diamanti, M. V., Ferone, C., Frontera, P., Gastaldi, M. M., Labianca, C., Lollini, F., Lorenzi, S., Manzi, S., Marroccoli, M., Notarnicola, M., Ormellese, M., Pastore, T., Pedeferri, M., Petrella, A., Redaelli, E., Roviello, G., Telesca, A., and Todaro, F.
- Subjects
alternative binders ,concrete durability ,design strategies ,rebars corrosion ,alternative binder ,Settore ING-IND/22 - Scienza e Tecnologia dei Materiali ,General Materials Science ,design strategie - Abstract
The topic of sustainability of reinforced concrete structures is strictly related with their durability in aggressive environments. In particular, at equal environmental impact, the higher the durability of construction materials, the higher the sustainability. The present review deals with the possible strategies aimed at producing sustainable and durable reinforced concrete structures in different environments. It focuses on the design methodologies as well as the use of unconventional corrosion-resistant reinforcements, alternative binders to Portland cement, and innovative or traditional solutions for reinforced concrete protection and prevention against rebars corrosion such as corrosion inhibitors, coatings, self-healing techniques, and waterproofing aggregates. Analysis of the scientific literature highlights that there is no preferential way for the production of “green” concrete but that the sustainability of the building materials can only be achieved by implementing simultaneous multiple strategies aimed at reducing environmental impact and improving both durability and performances.
- Published
- 2022
44. Graffiti Paint on Urban Trees: A Review of Removal Procedures and Ecological and Human Health Considerations
- Author
-
Valentina Roviello, Melinda Gilhen-Baker, Giovanni N. Roviello, Roviello, V., Gilhen-Baker, M., and Roviello, G. N.
- Subjects
graffiti ,vandalism ,Renewable Energy, Sustainability and the Environment ,volatile organic compounds ,Geography, Planning and Development ,tree-bark: painting ,nature conservation ,old-growth tree ,Building and Construction ,Management, Monitoring, Policy and Law - Abstract
Mature trees play a fundamental role in nature and are crucial to maintaining good air quality in the urban ecosystem where they reduce air pollution, lower the surface temperature, and emit medicinal volatile organic compounds which combine to improve human health and mental wellbeing. From an aesthetic and cultural point of view, they are true living monuments to be preserved. In both rural and city environments, it takes numerous years for trees to become mature enough to have a significant impact on our health and the current global climate changes together with high levels of pollution in urban environments and other anthropic factors such as vandalism constitute important obstacles to new tree growth. This clearly makes existing trees, especially old growth, far more valuable than we often realize. Regardless of their artistic quality and in some instances their positive messages, graffiti are still unacceptable on living organisms, especially older urban trees. They also have a significant environmental impact due to the emissions related to graffiti that are primarily based on anthropogenic volatile organic compounds (VOCs) which contribute to the formation of ground-level ozone. We reviewed the literature on graffiti and paintings applied on tree bark and ultimately found that oil-based paints in particular can damage tree life support systems. We herein also discuss graffiti prevention, the potential impact on human health related with graffiti removal, as well as methods for tree bark cleaning including, as suggested by different urban forestry specialists, the application of citrus-based products for 20–60 min before rubbing and rinsing or multiple 1–2 h treatments, in the case of recent or old graffiti, respectively.
- Published
- 2023
- Full Text
- View/download PDF
45. Development of Geopolymer-Based Materials with Ceramic Waste for Artistic and Restoration Applications
- Author
-
Laura Ricciotti, Alessio Occhicone, Claudio Ferone, Raffaele Cioffi, Oreste Tarallo, Giuseppina Roviello, Ricciotti, Laura, Occhicone, Alessio, Ferone, Claudio, Cioffi, Raffaele, Tarallo, Oreste, Roviello, Giuseppina, Ricciotti, L., Occhicone, A., Ferone, C., Cioffi, R., Tarallo, O., and Roviello, G.
- Subjects
ceramic wastes ,geopolymer ,mortars ,art and design ,recycling ,mortar ,General Materials Science ,ceramic waste - Abstract
This contribution presents the preparation and characterization of new geopolymer-based mortars obtained from recycling waste deriving from the production process and the “end-of-life” of porcelain stoneware products. Structural, morphological, and mechanical studies carried out on different kinds of mortars prepared by using several types of by-products (i.e., pressed burnt and extruded ceramic waste, raw pressed and gypsum resulting from exhausted moulds) point out that these systems can be easily cast, also in complex shapes, and show a more consistent microstructure with respect to the geopolymer paste, with a reduced amount of microcracks. Moreover, the excellent adhesion of these materials to common substrates such as pottery and earthenware, even for an elevated concentration of filler, suggests their use in the field of technical-artistic value-added applications, such as restoration, conservation, and/or rehabilitation of historic monuments, or simply as materials for building revetments. For all these reasons, the proposed materials could represent valuable candidates to try to overcome some problems experienced in the cultural heritage sector concerning the selection of environmentally friendly materials that simultaneously meet art and design technical requirements.
- Published
- 2022
- Full Text
- View/download PDF
46. Therapeutic management of a symptomatic Kaposi’s sarcoma patient with renal failure undergoing haemodialysis: A case report
- Author
-
Anna Passarelli, Giovanna Galdo, Teresa Pellegrino, Giandomenico Roviello, Michele Aieta, Gabriella Aviello, Raffaele Conca, Passarelli, A., Galdo, G., Pellegrino, T., Roviello, G., Aieta, M., Aviello, G., and Conca, R.
- Subjects
Chronic renal impairment ,Pomalidomide ,Kaposi sarcoma ,Dermatology ,Human herpesvirus 8 ,Haemodialysi - Abstract
Kaposi’s sarcoma (KS) is a rare inflammation- based vascular cancer involving the skin. The viral aetiology of KS is the Human Herpesvirus 8. KS may be frequently diagnosed in immunosuppressed kidneytransplanted patients, while is less common in patients with dialysis. It is known that various immunological abnormalities can lead to impaired immune status in uremic patients. It is noteworthy that despite the incidence of KS in patients with renal impairment, only few cases have reported efficacy and safety profile of KS targeting anti-cancer drugs in this kidney disease population. Herein, we report the first case of a symptomatic KS patient with renal disease in haemodialysis and focus on its therapeutic management. We also review the main data available from literature regarding the safety of KS therapy in dialysis patients.
- Published
- 2021
- Full Text
- View/download PDF
47. p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis
- Author
-
Daniele Generali, Raheleh Roudi, Giandomenico Roviello, Alberto D'Angelo, Praveen Neeli, DANIELE GENERALI, Navid Sobhani, Sobhani, N., Roviello, G., D'Angelo, A., Roudi, R., Neeli, P. K., and Generali, D.
- Subjects
Oncology ,Male ,p53 ,Pharmaceutical Science ,Cancer survival prognostic biomarker ,Meta-analysis ,P53 ,Serum p53 antibodies ,Autoantibodies ,Biomarkers, Tumor ,Female ,Humans ,Mutation ,Neoplasms ,Prognosis ,Retrospective Studies ,Survival Analysis ,Tumor Suppressor Protein p53 ,Organic chemistry ,Analytical Chemistry ,QD241-441 ,Retrospective Studie ,Drug Discovery ,Medicine ,P53 antibodies ,Tumor ,biology ,Hazard ratio ,Autoantibodie ,Data extraction ,Chemistry (miscellaneous) ,Molecular Medicine ,Animal studies ,Survival Analysi ,Antibody ,Human ,medicine.medical_specialty ,Prognosi ,cancer survival prognostic biomarker ,Article ,Internal medicine ,Meta-analysi ,Physical and Theoretical Chemistry ,serum p53 antibodies ,business.industry ,Cancer ,Diagnostic marker ,medicine.disease ,Serum p53 antibodie ,meta-analysis ,biology.protein ,Neoplasm ,business ,Biomarkers - Abstract
Importance: The protein p53 is an unequivocal tumor suppressor that is altered in half of all cancers. The immune system produces systemic p53 autoantibodies (p53 Abs) in many cancer patients. Objective: This systemic review and meta-analysis focuses on the prognostic value of p53 Abs expressed in the serum of patients with solid tumors. Data Sources: All the clinical investigations were searched on PubMed from the first study dated 1993 until May 2021 (date of submission of the manuscript). Study Selection: Studies were included that met the following criteria: (1) participants with cancer, (2) outcome results expressed in relation to the presence of a p53 antibody, (3) a primary outcome (disease-free survival, overall survival or progression-free survival) expressed as hazard ratio (HR). The following exclusion criteria were used: (1) insufficient data available to evaluate outcomes, (2) animal studies, (3) studies with less than 10 participants. As a result, 12 studies were included in the analysis. Data Extraction and Synthesis: PRISMA guidelines were used for abstracting and assessing data quality and validity by three independent observers. The summary estimates were generated using a fixed-effect model (Mantel–Haenszel method) or a random-effect model (DerSimonian–Laird method), depending on the absence or presence of heterogeneity (I2). Main Outcome(s) and Measure(s): The primary study outcome was to determine the prognostic value of p53 Abs from a large population of patients with solid tumors, as determined before data collection. Results: In total, 12 clinical studies involving 2094 patients were included in the meta-analysis, and it was determined that p53 Abs expression in the serum significantly correlated with poorer survival outcomes of cancer patients (95% CI 1.48 [1.24, 1.77], p <, 0.00001). Conclusions and Relevance: This is the first meta-analysis proving the diagnostic utility of p53-Abs for cancer patients in predicting poorer outcomes. The serum-p53 value (s-p53-value) may be useful for future theranostics.
- Published
- 2021
48. Forest-bathing and physical activity as weapons against COVID-19: a review
- Author
-
Melinda Gilhen-Baker, Caterina Vicidomini, Giovanni N. Roviello, Valentina Roviello, Roviello, V., Gilhen-Baker, M., Vicidomini, C., and Roviello, G. N.
- Subjects
Modalities ,Coronavirus disease 2019 (COVID-19) ,Bathing ,Physical activity ,business.industry ,Forest-bathing ,COVID-19 ,Physical exercise ,Review ,Disease ,Body immunity ,Environmental health ,Pandemic ,Environmental Chemistry ,Medicine ,Anxiety ,Volatile organic compounds ,medicine.symptom ,business - Abstract
Strengthening the immune system in order to better withstand the threat of COVID-19 is an important way to ensure the protection of our health against the current pandemic associated with SARS-CoV-2. There are many ways to achieve this, but with current circumstances, certain modalities stand out as being the most valid and are certainly worth greater consideration. Here we review the effects that particular immuno-strengthening activities can have on limiting the severity of COVID-19 disease as well as preventing virus infection. Physical activity, in particular, should not be discounted as an important method of prevention of viral diseases as it triggers many biological processes within the human body which in turn lead to heightened natural defences against viral infections. When exercise is performed in forested areas, these protective health benefits may be increased since many plant species emit biogenic volatile compounds (VOCs) which, when inhaled, have many protective properties. These VOCs have been shown in particular to have immunostimulatory effects on the human body and, thus, they could be of use in the prevention and/or treatment of COVID-19. Being amongst trees may also help to alleviate stress and anxiety, lowering cortisol levels and consequently helping the proper functioning of the immune system. In the following work, we have performed an analysis of the available scientific literature which looks at the effects of physical exercise as well as ‘forest-bathing’ on the immune system’s ability to fight disease, especially of course as it relates to COVID-19. Our review aims at shedding light on the benefits of exercising outdoors in green areas and suggests reforestation as a protective measure against future outbreaks.
- Published
- 2021
49. From Prebiotic Chemistry to Supramolecular Biomedical Materials: Exploring the Properties of Self-Assembling Nucleobase-Containing Peptides
- Author
-
Pasqualina Liana Scognamiglio, Ettore Napolitano, Chiara Platella, Domenica Musumeci, Giovanni N. Roviello, Scognamiglio, P. L., Platella, C., Napolitano, E., Musumeci, D., and Roviello, G. N.
- Subjects
Peptide Nucleic Acids ,Nanostructure ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,nucleopeptides ,Supramolecular chemistry ,Prebiotic ,Pharmaceutical Science ,Organic chemistry ,Nanotechnology ,Review ,010402 general chemistry ,01 natural sciences ,Analytical Chemistry ,Nucleobase ,QD241-441 ,Supramolecular ,Drug Discovery ,Self assembling ,Diagnostic ,Physical and Theoretical Chemistry ,nanomaterials ,Animal ,010405 organic chemistry ,Chemistry ,Peptide Nucleic Acid ,Social impact ,Self-assembly ,DNA ,Nanomaterial ,nucleobases ,PNAs ,0104 chemical sciences ,Nanostructures ,Nucleopeptide ,Prebiotic chemistry ,nucleic acids ,Nucleic acid ,Chemistry (miscellaneous) ,bioactivity ,Peptide ,Drug delivery ,peptides ,Molecular Medicine ,RNA ,Therapeutic ,PNA ,Human - Abstract
Peptides and their synthetic analogs are a class of molecules with enormous relevance as therapeutics for their ability to interact with biomacromolecules like nucleic acids and proteins, potentially interfering with biological pathways often involved in the onset and progression of pathologies of high social impact. Nucleobase-bearing peptides (nucleopeptides) and pseudopeptides (PNAs) offer further interesting possibilities related to their nucleobase-decorated nature for diagnostic and therapeutic applications, thanks to their reported ability to target complementary DNA and RNA strands. In addition, these chimeric compounds are endowed with intriguing self-assembling properties, which are at the heart of their investigation as self-replicating materials in prebiotic chemistry, as well as their application as constituents of innovative drug delivery systems and, more generally, as novel nanomaterials to be employed in biomedicine. Herein we describe the properties of nucleopeptides, PNAs and related supramolecular systems, and summarize some of the most relevant applications of these systems.
- Published
- 2021
50. EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
- Author
-
Giandomenico Roviello, Fabrizio Zanconati, A. Dicorato, Anna Ianza, A. Di Chicco, Daniele Generali, F. Variola, A. Guglielmi, Sara Tomasi, C. Biagi, Fabiola Giudici, Ianza, Anna, Di Chicco, A., Biagi, C., Giudici, F., Dicorato, A., Guglielmi, A., Variola, F., Tomasi, S., Roviello, G., Generali, D., and Zanconati, F.
- Subjects
0301 basic medicine ,Oncology ,Male ,Cancer Research ,medicine.medical_specialty ,Lung Neoplasms ,Concordance ,EGFR ,DNA Mutational Analysis ,Single Center ,Target therapy ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Carcinoma, Non-Small-Cell Lung ,medicine ,Biomarkers, Tumor ,Humans ,Liquid biopsy ,cfDNA ,Lung cancer ,Aged ,Retrospective Studies ,Aged, 80 and over ,Hematology ,business.industry ,General Medicine ,DNA, Neoplasm ,Middle Aged ,medicine.disease ,ErbB Receptors ,030104 developmental biology ,Circulating free DNA ,Italy ,Egfr mutation ,030220 oncology & carcinogenesis ,Mutation ,Female ,business ,Original Article – Cancer Research ,Cell-Free Nucleic Acids - Abstract
Purpose Monitoring mutation status in circulating free DNA (cfDNA) during target therapy could hold significant clinical importance in non-small cell lung cancer (NSCLC). Our aim is to establish if EGFR mutational status change on cfDNA has predictive value that can impact clinical management of NSCLC patients care. Methods This study included 30 patients with EGFR-mutated NSCLC. Blood samples were collected at diagnosis (T0) and in 19 patients during therapy (T1). Results Concordance between T0 and T1 EGFR mutation status for patients evaluable for both samples (n = 19) was 79%, with a sensitivity of 100% (95% CI: 55.5–100.0) and specificity of 60.0% (95% CI: 26.2–86.8). For the patients in oncological therapy with targeted drug and with T1 sample available (n = 18), survival outcomes were evaluated. For both mutation-negative T0 and T1 patients, 12-month progression-free survival (PFS) was 66.7% (95% CI: 27.2–100.0) and 12-month overall survival (OS) was 100% (95% CI: 1.00–1.00); for patients mutated both at T0 and T1, PFS was 22.2% (95% CI: 6.5–75.4%) and OS was 55.6% (95% CI: 20.4–96.1%). Conclusion EGFR mutation status can be assessed using cfDNA for routine purposes and longitudinal assessment of plasma mutation is an easy approach to monitor the therapeutic response or resistance onset.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.